FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th

Rhea-AI Summary

FSD Pharma, a life sciences holding company, announced participation in the KCSA Psychedelics Investor Conference on October 13-14, 2021. Interim CEO Anthony Durkacz and Lucid Psycheceuticals CEO Dr. Lakshmi P. Kotra will present live on October 13 at 2:30 p.m. ET. Investors can register for the event here. FSD Pharma focuses on innovative healthcare solutions and is actively pursuing acquisitions in the biotech space, particularly targeting mental health disorders and neurodegenerative diseases.

TORONTO, Oct. 13, 2021 /PRNewswire/ -- FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce that Anthony Durkacz, Interim CEO of FSD Pharma, and Dr. Lakshmi P. Kotra, CEO of FSD's wholly-owned subsidiary Lucid Psycheceuticals, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

Mr. Durkacz and Dr. Kotra will present live on Wednesday, October 13^th at 2:30 p.m. ET. Register to attend here.

For more information about the conference, or to schedule a one-on-one meeting with FSD's management team, please contact KCSA Strategic Communications at FSDPharma@kcsa.com.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Learn more about VIC and its events at www.virtualinvestorconferences.com.

About FSD Pharma
FSD Pharma is a life sciences holding company dedicated to building a portfolio of diversified therapeutic assets and innovative healthcare and biotech services. Currently, FSD is actively pursuing potential acquisition targets in the healthcare and biotech space to bring innovative treatments to market to treat various mental health disorders and neurodegenerative diseases.

Forward Looking Information

Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements regarding the terms and deliverables of the various agreements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties, and other factors.

Source: FSD Pharma Inc.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fsd-pharma-to-present-at-the-kcsa-psychedelics-virtual-investor-conference-on-october-13th-301399091.html

SOURCE VirtualInvestorConferences.com

FAQ

What is the purpose of FSD Pharma's participation in the KCSA Psychedelics Investor Conference on October 13, 2021?

FSD Pharma aims to present its portfolio and engage with investors at the KCSA Psychedelics Investor Conference.

Who will represent FSD Pharma at the KCSA Psychedelics Investor Conference?

FSD Pharma will be represented by Interim CEO Anthony Durkacz and Dr. Lakshmi P. Kotra, CEO of Lucid Psycheceuticals.

When will FSD Pharma present at the KCSA Psychedelics Investor Conference?

FSD Pharma will present live on October 13, 2021, at 2:30 p.m. ET.

How can investors register for the KCSA Psychedelics Investor Conference?

Investors can register for the conference by visiting this link.

What focus areas does FSD Pharma target in its business strategy?

FSD Pharma focuses on innovative healthcare solutions, particularly in mental health disorders and neurodegenerative diseases.

What is the significance of the KCSA Psychedelics Investor Conference for companies like FSD Pharma?

The conference provides a platform for companies to showcase their developments and connect with potential investors.